Autologous neoantigen-specific TCR-T cells

Neoantigen-specific T-cell receptor engineered T cells · National Cancer Institute (NCI)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous neoantigen-specific TCR-T cells, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies [Phase 1]

See pricing